Dhiren S Sheth1, Guy Cafri2, Elizabeth W Paxton2, Robert S Namba1. 1. Department of Orthopaedic Surgery, Southern California Permanente Medical Group, Irvine, California. 2. Surgical Outcomes and Analysis, Kaiser Permanente, San Diego, California.
Abstract
BACKGROUND: The purpose of this study was to compare the complications and mortality between bilateral simultaneous total knee arthroplasty (BTKA-Simultaneous) and bilateral staged TKA (BTK-Staged) while adjusting for differences in patient, surgeon, and hospital characteristics. METHODS: An integrated health care system total joint registry was used to compare patients undergoing BTKA-Simultaneous to BTKA-Staged. For outcomes related to revision and infection, the sample included 11,118 patients, and for outcomes of death, acute myocardial infarction, stroke, and venous thromboembolism, a subsample of 7991 patients with comorbidity data was selected. RESULTS: Overall death and complications in both groups were rare. The complication rates for BTKA-Simultaneous and BTKA-Staged were comparable: aseptic revision (1.17% vs 0.9%), septic revision/deep infection (0.8% vs 0.7%), death (0.28% vs 0.1%), and adverse events (2.49% vs 1.97%). In the adjusted models, there were no significant differences in any of the outcomes between the 2 groups. CONCLUSION: There is a lack of evidence to support superiority of either BTKA-Simultaneous or BTKA-Staged.
BACKGROUND: The purpose of this study was to compare the complications and mortality between bilateral simultaneous total knee arthroplasty (BTKA-Simultaneous) and bilateral staged TKA (BTK-Staged) while adjusting for differences in patient, surgeon, and hospital characteristics. METHODS: An integrated health care system total joint registry was used to compare patients undergoing BTKA-Simultaneous to BTKA-Staged. For outcomes related to revision and infection, the sample included 11,118 patients, and for outcomes of death, acute myocardial infarction, stroke, and venous thromboembolism, a subsample of 7991 patients with comorbidity data was selected. RESULTS: Overall death and complications in both groups were rare. The complication rates for BTKA-Simultaneous and BTKA-Staged were comparable: aseptic revision (1.17% vs 0.9%), septic revision/deep infection (0.8% vs 0.7%), death (0.28% vs 0.1%), and adverse events (2.49% vs 1.97%). In the adjusted models, there were no significant differences in any of the outcomes between the 2 groups. CONCLUSION: There is a lack of evidence to support superiority of either BTKA-Simultaneous or BTKA-Staged.
Authors: Matthew A Follett; Prerna Arora; William J Maloney; Stuart B Goodman; James I Huddleston; Derek F Amanatullah Journal: J Arthroplasty Date: 2022-01-10 Impact factor: 4.757
Authors: Michael Pitta; Christina I Esposito; Zhichang Li; Yuo-Yu Lee; Timothy M Wright; Douglas E Padgett Journal: J Arthroplasty Date: 2017-09-25 Impact factor: 4.757
Authors: Bella Mehta; Kaylee Ho; Jennifer Bido; Stavros G Memtsoudis; Michael L Parks; Linda Russell; Susan M Goodman; Said Ibrahim Journal: J Arthroplasty Date: 2020-11-02 Impact factor: 4.757
Authors: Mohammad Mahdi Sarzaeem; Farzad Amoozadeh Omrani; Mohammad Mahdi Omidian; Mohammad Ali Sahebalzamani; Ehsan Maniei Journal: Arch Bone Jt Surg Date: 2021-11